A

Avectas

33 employees

Avectas is a cell engineering technology company that enables drug developers to manufacture potent engineered cell therapies.

Basic info

biotechnology research

Biotechnology

Cell Engineering

Gene Therapy

Transfection

Gene Editing

Cell Therapy

CAR-T

CRISPR

Medical

Health Care

2011

$3.6M

from 1 investors over 1 rounds

A

Avectas raised $3.6M on May 1, 2018

Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)